A boy with an ultra-rare immune disease which can carry a “death sentence” is living a normal life after taking part in a ...

A four-year-old boy has been cured of a deadly immune disease by a new gene therapy. Eisa Hussain was born with a rare and ...

A four-year-old boy with a life-threatening immune disease is now living a normal life thanks to a pioneering gene therapy ...

A boy with an ultra-rare immune disease which can carry a “death sentence” is living a normal life after taking part in a groundbreaking gene therapy trial. Four-year-old Eisa Hussain now enjoys ...

An investigational gene therapy has successfully restored immune function in all nine children treated with the rare and life ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China (W.L., J.H., Y.D., J.W., Y.C.).

A case of biotinidase deficiency (BD) in Tunisia was initially diagnosed as ... Read more about NMOSD differential diagnosis The patient initially presented with itchy and crusty papular erythematous ...

The company’s solutions include ex vivo lentiviral vector treatments for Fanconi anemia, leukocyte adhesion deficiency-I ... Rocket also finished enrolling patients in its Phase 1 trial for ...

We recently published a list of 10 Stocks Under $10 that Will Triple.In this article, we are going to take a look at where Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) stands against other stocks ...

As the countdown to the launch of its first therapeutic continues, Rocket Pharmaceuticals is fueling up its commercial team. The biotech on Monday appointed Sarbani Chaudhuri as its new chief ...